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Process outline - comparison

Drug
+
Excipients

Tablets

3D printing (FDM)
Hot-melt extrusion
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Motivation + advantages


Personalized dosing, flexibility



Multi-drug loading, multilayer tablets (multiple nozzles)



Adjustable geometry and porosity (=> dissolution rate)



Potential for scale-up (printhead arrays)



August 2015 – First commercial application - Spritam
(Levetiracetam) approved by FDA

FDA-approved Spritam tablets

FDM-printed tablet

Surface of a FDM tablet
(SEM)
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ZipDose Technology



First approved 3D-printed dosage form
High dose of the drug Levetiracetam, immediate release

06.05.2020

4

ZipDose Technology



First approved 3D-printed dosage form
High dose of the drug Levetiracetam, immediate release
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Solid paste extrusion




Easy formulation (drug can be in a dispersion)
No thermal processing, but time-consuming paste preparation
Multitablet – up to 5 different drugs with varying release rates
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Solid paste extrusion
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Ink-jet 3D printing





High resolution (30µm)
Time-consuming process, friability
Typically involves solvent evaporation
Example:
Heated chamber, Fenofibrate + beeswax
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Stereolitography (SLA)




Excipients – photo-curable resins => UV radiation
High resolution (10µm), no external heating
“Applicable” for most drugs, UV-drug interaction poses risk

06.05.2020
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Selective light sintering (SLS)




Sintering of excipients + drug in powder form
Material loss, rinsing step
Example: Kollicoat IR, Eudragit L100-55 + Paracetamol

06.05.2020
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Fused deposition modelling
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General filament composition


An approved drug (API)
- thermal stability of the molecule



Polymer matrix (Soluplus, Eudragit XX, Kollidon XX, cellulose derivates)
- biodegradable approved excipients, solubilize/amorphize the drug
- suitable thermal and rheological properties



Functional additives – plasticizers (PEG XX, glycerol, …),
glidants/anticaking agents (Talcum, MgStearate), disintegrants (Ac-Di-Sol,
starch), desiccants (citric acid anhydrous)
- affect mechanical properties of the filaments, process temperature,
properties of the powder form, dissolution / disintegration kinetics

06.05.2020
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Important filament properties
& extrusion parameters









Mechanical properties (Young‘s modulus, hardness)
Shape homogeneity (affected by extrusion parameters)
Heat transfer rate (heating & cooling)
Surface roughness / stickiness
Lowest achievable process temperature
Homogeneity of composition (drug content)
Drug structure (amorphous / crystalline) and stability
Dissolution / disintegration rate
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Pharma-grade hot-melt extrusion





=> Anticaking agents (glidants)

Filament cooling
Filament conveying
Powder
agglomeration
Cavity formation

Rheology of the powder form

Inner structure of the filaments




Mechanical properties affected by microporosity (in some
cases up to 40% v/v)
Micro-CT, Image analysis and reconstruction
Porosity lowered by adding dessiccants or glidants

Important filament properties
& extrusion parameters

06.05.2020
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Printing parameter adjustment




Gear speed, inner filling characteristics, nozzle movement
speed, filament retraction, perimeter characteristics, …
Printing temperature, bed temperature, …
Printing resolution distribution, layer overlap, nozzle distance,
…
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Drug structure analysis

Amorphous / crystalline after extrusion?
=> X-ray powder diffractometry, differential scanning calorimetry
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Homogeneity of drug content
UV spectroscopy:




Absorpce of excipients
Light scattering
Solubility

HPLC:
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Disintegration enhancement
=> Effervescent compounds – disintegration due to CO2
production, but leads to increased porosity and
brittleness
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„Exploding“ effervescent tablet


Hollow tablet filled with effervescent mixture
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Virtual prototyping and parametric design
of 3D printed tablets
based on the solution of inverse problem
Desired result

Initial product parameters

1) Parametric series of tablets with varying internal porosities
=> library of dissolution profiles, superpositions
2) Adjusting parameters of a mathematical model to accurately predict
dissolution and intrapolate between measured data
3) Superpositions of different porosities to achieve new release profiles
4) A desired release profile met by iterative programming
=> tablet design and printing, experimental verification
06.05.2020
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Virtual prototyping and parametric design
of 3D printed tablets
based on the solution of inverse problem
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Virtual prototyping and parametric design
of 3D printed tablets
based on the solution of inverse problem
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Dissolution of single-porosity tablets
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Model overview, parameter fitting
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Model overview, parameter fitting
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Model overview, parameter fitting
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Conclusion






Parametric study of composition and process parameters led to
achieving FDM printability of 8 drugs
Products analyzed (homogeneity, drug structure, material porosity,
powder rheology, mechanical stability, in vitro dissolution, …)
Dissolution kinetics predicted through mathematical 3D modelling,
linked to tablet structure
Employing genetic (evolutional) algorithm to find desired tablet
structure
Mapping and predicting “printability” for new drugs

res = 200 µm

res = 100 µm
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